Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies

Following the clinical success of cancer immunotherapies such as immune checkpoint inhibitors blocking B7/CTLA-4 or PD-1/PD-L1 signaling and ongoing numerous combination therapies in the clinic,3 bispecific antibodies (BsAbs) are now emerging as a growing class of immunotherapies with the potential...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: You, Gihoon, Won, Jonghwa, Lee, Yangsoon, Moon, Dain, Park, Yunji, Lee, Sang Hoon, Lee, Seung-Woo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310217/
https://ncbi.nlm.nih.gov/pubmed/34358141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados